Atlas Trials

A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1)

Clinical trial NCT06515002 · TERMINATED

Trial details

NCT number
NCT06515002
Sponsor
Boehringer Ingelheim
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2024-11-04
Primary completion
2026-02-03
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.